NEWS: 2/26/2009

Raptiva linked to progressive multifocal leukoencephalopathy, also known as PLM is a side effect of this psoriasis drug. Other know Raptiva side effects include: Brain Infection, and  Progressive Brain Disease.

What is PML? (Progressive Multifocal Leukoencephalopathy)

PML is a rare brain infection that tends to affect patients whose immune systems are in a weakened state.  In fact, the active virus associated with PML, Polyomavirus JC, or the JC virus, is carried and present in most people, but those with healthy immune systems are never affected by it.  However, this is not apparently the case with those who have used Raptiva.

What’s even more problematic is that the symptoms of PML can be very diverse, making a clear diagnosis difficult.  The reason for this difficulty is that the JC virus causes a loss of white matter known as myelin in the brain that affects several areas where the needed protection offered by myelin is no longer present.

If injured from Raptiva please visit this website to contact a Raptiva Lawyer Today. 

Other facts on Raptiva can be found at this Raptiva and PML information web site.

This Raptiva and PML information was updated on 2/26/2009.

NEWS: February 19, 2009  FDA ALERT FOR RAPTIVA:

FDA has just issued a Public Health Advisory to notify healthcare professionals of three confirmed, and one possible report of progressive multifocal leukoencephalopathy (PML), a rare brain infection, in patients using the psoriasis drug Raptiva.

In October 2008, the labeling for Raptiva was changed to highlight, in a Boxed Warning, the risks of life-threatening infections, including PML. In addition, FDA directed Genentech, the manufacturer of Raptiva, to develop a Risk Evaluation and Mitigation Strategy, or REMS, to ensure that patients receive risk information about Raptiva.
The FDA is reviewing this latest information. The agency will take appropriate steps to ensure that the risks of Raptiva do not outweigh its benefits, that patients prescribed Raptiva are clearly informed of the signs and symptoms of PML, and that health care professionals carefully monitor patients for the possible development of PML. The Public Health Advisory provides recommendations for h ealthcare providers and patients when treatment with this product is considered.

Read the MedWatch safety summary, including links to the Public Health Advisory and News Release, at:
http://www.fda.gov/medwatch/safety/2009/safety09.htm#Raptiva

October 24, 2008

Raptiva is a drug that’s given to help treat psoriasis, and it’s generally given once per week to patients. It’s administered via an injection, and its main function is to suppress the patient’s immune system somewhat in order to alleviate the symptoms of their existing psoriasis. It’s generally been viewed in a positive light in terms of its results, but recent reports have prompted the FDA to issue the statement at issue here.
Raptive Side Effect Problems

Reports have surfaced in which patients have complained of the following side effects and symptoms while using Raptiva:

* Fever or chills
* Sore throat
* Coughing
* Congestion or other signs of infection
* Redness, pain, or swelling of a skin wound
* Burning or difficult urination

FDA Warning for Raptiva.

These symptoms have been found to potentially lead Raptiva users to develop the following conditions as a result of using this medication:

* Bacterial sepsis
* Viral meningitis
* Invasive fungal disease
* Progressive multifocal leukoencephalopathy (PML)

Specifically, one report seems to have prompted the FDA into action. It was the case of a 70-year-old man who had been using Raptiva for four years, or almost since the date it was originally approved for use. He developed a case of PML, which is a viral condition that attacks the brain progressively, and he ultimately was killed as a result.

In reaction to these reports, the FDA has recently issued a public alert that’s designed to help provide notice to medical professionals and the public at large. In furtherance of this notice, the FDA will now require a warning label to be affixed to every container of Raptiva that warns of the potential for these side effects.

For Raptiva Lawsuit information please visit this website Raptiva Lawyer

NEWS: January 8, 2009.

New 2009 California DUI laws & San Diego DUI Lawyer Information

New California DUI laws have now gone into effect starting January 1, 2009.

The new DUI laws include a new Zero Tolerance Law and Ignition Interlock Device Law.

Driving Under the Influence (DUI) Zero Tolerance (AB 1165, Maze) This new law prohibits a convicted DUI offender from operating a motor vehicle with a blood alcohol level (BAC) of .01 percent or greater while on probation for DUI. The law requires the driver to submit to a Preliminary Alcohol Screening (PAS) test, a portable breath test to determine the presence of alcohol. If the driver refuses, or if the driver submits and has a BAC of .01 or greater, a citation will be issued, the driver’s license will be taken and driving privileges will be suspended. In addition, the vehicle will be impounded.

Ignition Interlock Devices (IID) (SB 1190, Oropeza) This new law reduces the BAC from .20 percent to .15 percent or more at the time of arrest to trigger a requirement for the court to give heightened consideration for the installation of an IID for a first-time offender convicted of DUI of an alcoholic beverage.

Ignition Interlock Devices (SB 1388, Torlakson) Effective July 2009, this new law transfers authority for the administration of mandatory IID programs from the state courts to the Department of Motor Vehicles (DMV). This law also authorizes the DMV to require any driver convicted of driving with a suspended license due to a prior conviction for DUI to install an IID in any vehicle that the offender owns or operates.

Alcohol-Related Reckless Driving (AB 2802, Houston) This new law requires the court to order a person convicted of alcohol-related reckless driving to participate in a licensed DUI program for at least nine months, if that person has a prior conviction for alcohol-related reckless driving or DUI within ten years. Additionally, the court is required to revoke the person’s probation for the failure to enroll in, participate in, or complete a licensed DUI program.

 If you were arrested for a DUI please visit this San Diego DUI Lawyer website.

NEWS: November 11, 2008

The economic downturn has forced many of us across San Diego California to fall behind on their mortgage payments and others to face an uncertain future with foreboding because interest rates are scheduled for adjustment. For many more the fear of losing one’s home has become a reality as foreclosure proceedings have been threatened by the bank.

To address this crisis a home loan modification web site has established a new home loan modification service department within the KSPLC firm dedicated solely to helping you keep your home and not be forced out by your lender. If you or someone you care about are experiencing difficult times and are concerned about falling behind in your mortgage payments or, worse, losing your home, contact our firm immediately.

Additionally, if you feel you are drowning in credit card payments and other bills we are offering debt negotiation services which, on many occasions, can cut your bills in half. We will work directly with your lending institution to restructure your existing loans so that you can keep your home, try to save your credit and brave this economy until brighter days arrive.

Questions about What is a Home Loan Modification in San Diego, California:

* Are you behind on your mortgage payments?
* Do you have an ARM mortgage that has reset or is about to reset?
* Do you owe more on your mortgage than the value of your home?

We will negotiate with your lender to lower your monthly payment and interest rate.
* We keep you in your home.
* We save your credit.

This is not a short sale. It is not a bankruptcy. For more information on contacting a Home Loan Modification Lawyer visit this web site: http://www.pacificlawcenter.com/html/bankruptcy-home-loan.html

NEWS: October 23, 2008

Some of the common side effects noted for the oral contraceptive birth control pill called Yasmin or Yas may include an increased risk of the following serious adverse reactions has been associated with the use of Yasmin.

*  Thrombophlebitis
* Arterial thromboembolism
* Pulmonary embolism
* Myocardial infarction
* Cerebral hemorrhage
* Cerebral thrombosis
* Hypertension
* Gallbladder disease
* Hepatic adenomas or benign liver tumors

The following are the most common adverse events reported with use of YASMIN  during the clinical trials, occurring in > 1% of subjects and which may or may not be drug related: Headache, Menstrual Disorder, Breast Pain, Abdominal Pain, Nausea, Leukorrhea, Flu Syndrome, Acne, Vaginal Moniliasis, Depression, Diarrhea, Asthenia, Dysmenorrhea, Back Pain, Infection, Pharyngitis, Intermenstrual Bleeding, Migraine, Vomiting, Dizziness, Nervousness, Vaginitis, Sinusitis, Cystitis, Bronchitis, Gastroenteritis, Allergic Reaction, Urinary Tract Infection, Pruritus, Emotional Lability, Surgery, Rash, Upper Respiratory Infection.

If you’ve experienced any side effects from Yasmin Birth Control please visit this web site for more information

Yasmin Lawyer 

Yasmin Side Effects and Lawsuit information updated 10/23/2008.

NEWS: October 20, 2008 

The birth control industry has never really been without controversy for different reasons.  Obviously, and especially when birth control products began to invade the market, different groups and individuals objected to their presence based on moral grounds.  However, the industry continued to grow and expand, and in present times, birth control products generate billions of dollars every year for the companies who own, manufacture, distribute and market them to consumers, either directly or by way of prescriptions.

One such product is the pill known as Yasmin, which is also known as “Yas” or “Yaz” by many who are familiar with it.  Yasmin has been on the market since 2001, when it was ultimately approved by the US Food and Drug Administration (FDA) for marketing and distribution in the American market.

Yasmin has proven to be big business as well, and estimates show that in the calendar year of 2007, the drug generated almost $500 million in revenue in the United States alone.  There are many reasons for this growth, including its early effectiveness in preventing unwanted pregnancies, ease of use, as it’s simply a once-daily pill to be taken, as well as its perceived safety.

Yasmin Side effects include:

Unfortunately, as is often the case with new and ‘innovative’ drugs that hit the market, Yasmin has encountered recent problems and has been linked to the development of serious side effects.  These side effects include:

• Deep vein thrombosis (DVT)
• Pulmonary embolism (PE)
• Stroke
• Heart attack
• Death

Injured or Hurt from Yasmin:

If you have been injured as a result of using Yasmin please visit this website for more information on a Yasmin Lawsuit

NEWS: October 2, 2008.

According to research published in the Journal of the American Medical Association, those using the Spiriva Handihaler or a generic inhaler called ipratropium, could face an increased risk of cardiac death, heart attacks or strokes when compared with those who received a placebo or other drugs.

Spiriva Handihaler (tiotropium) is an inhaled medication from Boehringer Ingelheim Pharmaceuticals Inc. and jointly marketed by Boehringer and Pfizer Inc. in the U.S. It was approved in 2004 as a once-daily long-term treatment of bronchospasm linked with chronic obstructive pulmonary disease (COPD).

Ipratropium is the generic name for Atrovent, which is also manufactured by Boehringer. It was approved in 1998 for treatment of COPD.

Researchers analyzed data from 17 randomized studies, comparing mainly older people on either drug to those on placebos or other drugs. It was found that patients on Spiriva or ipratropium had a 58% higher risk of developing heart problems, both fatal and nonfatal, including heart attacks.

If you or someone you know has been hurt or injured from a Spiriva Handihaler click here.

It is a huge agency that covers not only railway safety but many other categories of transportation safety.  They include aviation, highway, marine, and pipeline & hazardous materials.

The NTSB is an independent agency.  Its core objective is to determine the probable causes of a transportation accident while promoting transportation safety.  The Board is responsible for investigating and accident, performing safety studies, and evaluating government agency programs’ effectiveness on accident prevention.

The Board also writes safety recommendations based on their investigations and studies with the goal of preventing future accidents thus saving lives and reducing injuries.  These recommendations are one of NTSB’s biggest focuses.

The NTSB investigates the probable cause in all US civil accidents, selected highway accidents, railroad accidents involving passenger trains or a train accident that has fatalities or major property damage.  This list also includes major marine accidents, pipeline accidents with fatalities or property damage, releases of  hazardous materials, and transportation accidents that are recurring.

The NTSB’s website includes updates on ongoing investigations including the Metrolink train accident.

NEWS: September 22, 2008

If you or someone you know was hurt or injured in the Los Angeles Metrolink Train Crash that took place on September 12, You have a limited amount of time for any lawsuit claim for the Metrolink train accident.

The statute of limitations for the LA Metrolink Train accident is 6 months from the date of the accident.

This means that if you are thinking about starting a lawsuit for the LA Metrolink train accident, you should be in contact with a lawyer of law firm that handles these type of train accident litigation.

Below are a few law firms that can provide a free legal consultation for this tragic Metrolink train accident.

 MetroLink Lawsuit Attorney

Metrolink Lawsuit information

Metrolink Law firm and Lawyer

Blog Updated for News about the Metrolink Train Accident and free lawyer consultation September 22, 2008.

NEWS: September 19, 2008

In Los Angeles another train accident has occurred, this time it was a Metro Blue Line train that crashed into a transit bus.

The cause of the accident isn’t known at this time.

The accident happened a week after a commuter train carrying 220 people rolled past stop signals and barreled head-on into a Union Pacific train in Chatsworth, north of Los Angeles. The accident, the nation’s deadliest rail disaster in 15 years, left train cars so mangled that some bodies had to be removed in pieces. The crash injured 138 people.

For complete details on the LA Chatsworth Metrolink Train Accident please visit the following websites:

Metrolink Lawyer – Attorney

Metrolink Lawsuit information

Hurt in the Los Angeles Metrolink Train Crash

Victims hurt or injured in the LA Metrolink Train Accident